Tech Company Financing Transactions
GlycanAge Funding Round
GlycanAge, based in Newcastle Upon Tyne, secured $4.2 million from Launchub Ventures and Kadmos Capital.
Transaction Overview
Company Name
Announced On
2/19/2024
Transaction Type
Venture Equity
Amount
$4,200,000
Round
Seed
Investors
Launchub Ventures (Lead Investor)
Proceeds Purpose
Seed round will enable the company to move beyond the longevity space in stretch deeper into the potentially even more lucrative diagnostics market and establish a clear regulatory strategy and product pipeline.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
The Catalyst; 3 Science Square, Newcastle Helix
Newcastle Upon Tyne, NE4 5TG
UK
Newcastle Upon Tyne, NE4 5TG
UK
Phone
Undisclosed
Website
Email Address
Overview
GlycanAge is a biological age test paired with expert advice to help guide your wellness. It determines your biological age by measuring chronic inflammation in your system - which is directly related to your lifestyle. GlycanAge is based on more than 30 years of scientific research and over 200,000 tests. Our scientists regularly publish in world renowned Medical Journals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Gordan Lauc
Founder
Nikolina Lauc
Founder
Carlos Virella
Browse more venture capital transactions:
Prev: 2/19/2024: BOX ID venture capital transaction
Next: 2/19/2024: Unfabled venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs